Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 3
1967 1
1969 3
1970 4
1971 4
1972 4
1973 2
1974 1
1975 1
1976 1
1977 4
1978 9
1979 5
1980 5
1981 3
1982 8
1983 6
1984 7
1985 9
1986 6
1987 6
1988 10
1989 7
1990 3
1991 5
1992 5
1993 2
1994 3
1995 4
1996 2
1997 5
1998 6
1999 8
2000 14
2001 16
2002 10
2003 21
2004 14
2005 22
2006 16
2007 19
2008 15
2009 26
2010 17
2011 22
2012 22
2013 24
2014 45
2015 55
2016 30
2017 49
2018 57
2019 81
2020 104
2021 108
2022 119
2023 8
Text availability
Article attribute
Article type
Publication date

Search Results

948 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: pirjamadi
Page 1
Acute Cholangitis: Causes, Diagnosis, and Management.
An Z, Braseth AL, Sahar N. An Z, et al. Gastroenterol Clin North Am. 2021 Jun;50(2):403-414. doi: 10.1016/j.gtc.2021.02.005. Epub 2021 Apr 23. Gastroenterol Clin North Am. 2021. PMID: 34024448 Review.
Retraction.
[No authors listed] [No authors listed] J Cell Physiol. 2022 May;237(5):2602. doi: 10.1002/jcp.30743. Epub 2022 Apr 13. J Cell Physiol. 2022. PMID: 35416281
Retraction: "Zerumbone inhibits epithelial-mesenchymal transition and cancer stem cells properties by inhibiting the beta-catenin pathway through miR-200c," by Fatemeh Karimi Dermani, Razieh Amini, Massoud Saidijam, Mona Pourjafar, Sahar Saki, Rezvan Najafi. Journal of Cel …
Retraction: "Zerumbone inhibits epithelial-mesenchymal transition and cancer stem cells properties by inhibiting the beta-catenin pathway th …
Introducing new group leaders: Sahar Melamed.
[No authors listed] [No authors listed] Mol Cell. 2022 Nov 17;82(22):4189-4191. doi: 10.1016/j.molcel.2022.10.029. Mol Cell. 2022. PMID: 36400003
Sahar Melamed spoke with Molecular Cell about his interdisciplinary group at the Hebrew University of Jerusalem, which applies experimental and computational approaches to studying regulatory RNAs in bacteria. ...
Sahar Melamed spoke with Molecular Cell about his interdisciplinary group at the Hebrew University of Jerusalem, which applies experi
Response.
Tolia VJ, O'Hara DN, Ullah KI, Ahmad S. Tolia VJ, et al. Chest. 2020 Apr;157(4):1044-1045. doi: 10.1016/j.chest.2020.01.005. Chest. 2020. PMID: 32252913 No abstract available.
If We Build It, They Will Come…Maybe.
Sahar L, Smith RA. Sahar L, et al. Chest. 2021 Jul;160(1):34-35. doi: 10.1016/j.chest.2021.04.029. Chest. 2021. PMID: 34246373 No abstract available.
948 results